Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Oncology|November 7, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinomaValentina Panzeri, Isabella Manni, Alessia Capone, et al.
Nucleic Acids Research|December 21, 2016
Binding site density enables paralog-specific activity of SLM2 and Sam68 proteins in Neurexin2 AS4 splicing controlMarina Danilenko, Caroline Dalgliesh, Vittoria Pagliarini, et al.
Science Advances|May 1, 2026
HnRNP C binding to inverted <i>Alu</i> elements protects the transcriptome from pre-mRNA circularizationAlberto Marini, Consuelo Pitolli, Sabrina Ciccone, et al.
Cell Reports|June 4, 2020
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing CerebellumDonatella Farini, Eleonora Cesari, Robert J Weatheritt, et al.
Nucleic Acids Research|February 7, 2024
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex developmentEleonora Cesari, Donatella Farini, Vanessa Medici, et al.
Journal of Medicinal Chemistry|August 11, 2025
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal CancerDomiziana Masci, Lele Ling, Lian Yang, et al.
Cell Reports. Medicine|February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancerVeronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Journal of Medicinal Chemistry|November 7, 2024
Development of <i>N</i>-(4-(1<i>H</i>-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic StabilityMichela Puxeddu, Lele Ling, Silvia Ripa, et al.
Cell Death & Disease|March 25, 2026
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cellsDalila Boi, Giulia Fianco, Federica Polverino, et al.
ACS Pharmacology & Translational Science|July 20, 2023
Novel <i>N</i>-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer AgentMarianna Nalli, Laura Di Magno, Yichao Wen, et al.
Pageof 4